The FDA issued a complete response letter for SYD-101, citing insufficient evidence of effectiveness despite achieving ...
Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...
Developed by Paris, France-based EssilorLuxottica and made for children as young as 6, the brand-new Stellest lenses slow the ...
Please provide your email address to receive an email when new articles are posted on . Axial length growth was significantly lower in the red light therapy group during the first year. There was no ...
The Myopia and Presbyopia Treatment Market is experiencing significant growth due to the increasing prevalence of vision loss from nearsightedness and age-related presbyopia. Elderly people and ageing ...
New York, USA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care ...
Patients with high myopia had less favorable refractive results after LASIK but still had satisfactory short-term outcomes, ...
Brianna Rhue, OD, FAAO, discusses the pitfalls of myopia treatment and accessibility of that treatment. There are still some pitfalls associated with myopia treatment in children, according to Brianna ...
iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia
Funding will support development of a first-in-class topical eye drop designed to slow the progression of myopia in children iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback